Current skin care treatment protocols typically involve the absorption or penetration of a skin formation into the epidermis for effective results. However, the Stratum Corneum (SC), the topmost and thinnest layer of the epidermis, is said to be 1000 times more resistive as a natural barrier than the underlying viable epidermis. As a result, skin formulations applied to the skin often do not reach the lower layers of the epidermis as intended.
Current techniques for aiding infusion of a skin formulation having active materials to the epidermis include micro needles, electrophoresis, ultrasound, dermal/micro-dermal abrasion, and chemical peels. These methods are either not effective on all types of fluids or are associated with pain, bleeding, and infection.
However, currently there are no devices and/or methods that improve infusion of skin formula penetration into the SC without affecting the underlying viable tissues, and which preferably work in a painless, infection-free manner.
This summary is provided to introduce a selection of concepts in a simplified form that are further described below in the Detailed Description. This summary is not intended to identify key features of the claimed subject matter, nor is it intended to be used as an aid in determining the scope of the claimed subject matter.
In accordance with aspects of the present disclosure, a skin treatment apparatus is provided. The apparatus includes a shear inducing head having a first friction surface adjacent a first edge, and a second friction surface adjacent a second edge, which is spaced a constant distance from the first edge in order to form a gap having a width of between about 0.003 mm and 0.200 mm. The apparatus also includes a drive motor assembly configured to impart an oscillating motion to the shear inducing head such that the first friction surface moves with respect to the second friction surface in an oscillating manner.
In accordance with another aspect of the present disclosure, a method is provided for applying shear force to a subject's skin. The method includes oscillating a shear inducing head having a first member oscillating at a selected amplitude and frequency with respect to a second member. The first and second members are spaced a constant distance apart and define first and second gripping surfaces, respectively. The method also includes contacting the shear inducing head to a region of the subject's skin.
In accordance with another aspect of the present disclosure, a method is provided for infusing a skin formulation into at least a portion of the user's epidermis, including the SC. The method includes applying shear force to a region of a subject's skin, thereby defining sheared areas of skin, and applying a skin formulation to the sheared areas of skin.
The foregoing aspects and many of the attendant advantages of this disclosed subject matter will become more readily appreciated as the same become better understood by reference to the following detailed description, when taken in conjunction with the accompanying drawings, wherein:
The detailed description set forth below in connection with the appended drawings where like numerals reference like elements is intended as a description of various embodiments of the disclosed subject matter and is not intended to represent the only embodiments. Each embodiment described in this disclosure is provided merely as an example or illustration and should not be construed as preferred or advantageous over other embodiments. The illustrative examples provided herein are not intended to be exhaustive or to limit the claimed subject matter to the precise forms disclosed.
The following discussion provides examples of treatment protocols and associated devices that relate to skin care. In some treatment protocols described herein, devices and/or methods are provided that prepare a subject's skin to receive skin formulations having one or more active materials. In particular, the following discussion provides examples of devices and/or methods for treating a subject's skin in order to increase the skin's ability for skin formulations to penetrate or infuse into the SC layers thereof. As will be described in more detail below, the treatment protocol includes the application of shearing forces in order to part, tear, or form fissures only in the Stratum Corneum (SC) of the subject's skin without inducing trauma in viable skin layers below the SC.
Embodiments of the present disclosure include devices and methods that employ a skin contacting head with at least one surface or part that is movable with respect to another adjacent surface or part. In some embodiments, either one or the other surface or part can be moved with respect to the other. In other embodiments, both parts are movable opposite one another. The moving part or parts of the device, when applied to either wet or dry skin, aim to produce surface shear regions that create tears or fissures in only the SC.
In the following description, numerous specific details are set forth in order to provide a thorough understanding of one or more embodiments of the present disclosure. It will be apparent to one skilled in the art, however, that many embodiments of the present disclosure may be practiced without some or all of the specific details. In some instances, well-known process steps have not been described in detail in order not to unnecessarily obscure various aspects of the present disclosure. Further, it will be appreciated that embodiments of the present disclosure may employ any combination of features described herein.
Turning now to
As shown in the enlarged, partial cross-sectional view of
Referring to
In some embodiments, the drive motor assembly 60 is configured to oscillate the central disc 36, back and forth with respect to the outer ring 32 between an angular range or amplitude α (see
While in the embodiments described above, the outer ring 32 is fixed in place while the central disc 36 is rotatable in an oscillatory manner as shown in
In accordance with aspects of the present disclosure, the gripping surface 40 adjacent an inner edge 42 of outer ring 32 and gripping surface 46 adjacent an outer edge 48 of the central disc 36 can be provided with a friction enhancing texture, as shown in
One example of a method for treating a subject's skin with the apparatus 20 will now be described with reference to
Once contacting the subject's skin, the movement of the adjacent surfaces 40 and 46 creates highly localized shear forces suitable to open only the stratum corneum (SC) of the subject's skin. When the edges 42 and 48 slide past each other a pre-determined amount α, sufficient shear levels are produced to open or part the skin in a shear region. The shear levels are a function of the gap A, the amount of respective movement α, and the static friction between the surfaces 40 and 46 and the subject's skin. As a result, layers of the SC part or open, creating fissures therein within the intended shear region. Parting of the skin can refer to a rupture of the desmosome and lipid binding of the corneocytes of the SC.
The shear inducing head 24 can be traversed over one or more areas of the subject's skin. Once the desired areas of the subject's skin are treated, the apparatus 20 can be removed from the subject's skin, and the apparatus powered down. A skin formulation can then be applied to the treated areas of the subject's skin.
The skin formulation can be a “dermatological composition” or a “cosmetic composition.” Among the compositions that can be applied to the skin by the dispensing device and used conjointly with the workpiece/appliance may be one or more of: slimming agents, humectants or moisturizers, anti-ageing substances, in particular “anti-wrinkle” substances, anti-oxidants, fat-restructuring substances, substances acting on the micro-circulation, biological active substances known for their actions on the mechanotransduction chain, tensioning agents which fix the immediate deformations conferred by the suction on the surface of the skin and thereby lead to a temporary smoothing of the skin, and any dermatological compositions including but not limited to a) econazole and its salts, like sodium, potassium, lithium, calcium, magnesium, nitrate or ammonium salts; b) flavones such as flavone, apigenine, chrysine, flavanone, quercetine; and c) retinoic acid.
To this point, the various embodiments have employed a shear inducing head 24 that employs a rotationally (i.e., angularly) oscillatory motion to one or both head components 32 and 36. It will be appreciated that in other embodiments of the present disclosure, the shear inducing head 24 may employ linearly oscillatory, sometimes referred to as reciprocating, motion to one or both head components, such as parallel disposed members 88 and 90, as shown schematically in
It should be noted that for purposes of this disclosure, the use of “including,” “comprising,” or “having” and variations thereof is meant to encompass the items listed thereafter and equivalents thereof as well as additional items. Unless limited otherwise, the terms “connected,” “coupled,” and “mounted” and variations thereof herein are used broadly and encompass direct and indirect connections, couplings, and mountings.
The principles, representative embodiments, and modes of operation of the present disclosure have been described in the foregoing description. However, aspects of the present disclosure which are intended to be protected are not to be construed as limited to the particular embodiments disclosed. Further, the embodiments described herein are to be regarded as illustrative rather than restrictive. It will be appreciated that variations and changes may be made by others, and equivalents employed, without departing from the spirit of the present disclosure. Accordingly, it is expressly intended that all such variations, changes, and equivalents fall within the spirit and scope of the present disclosure, as claimed.
Number | Name | Date | Kind |
---|---|---|---|
4777599 | Dorogi | Oct 1988 | A |
5084046 | Isack | Jan 1992 | A |
5416942 | Baldacci | May 1995 | A |
5647841 | Groenewold | Jul 1997 | A |
5891063 | Vigil | Apr 1999 | A |
5964729 | Choi | Oct 1999 | A |
6032313 | Tsang | Mar 2000 | A |
6139553 | Dotan | Oct 2000 | A |
7157816 | Pilcher | Jan 2007 | B2 |
7363673 | Schonewille | Apr 2008 | B2 |
7678120 | Shadduck | Mar 2010 | B2 |
7786626 | Reishus | Aug 2010 | B2 |
8048089 | Ignon | Nov 2011 | B2 |
20020049398 | Wevers | Apr 2002 | A1 |
20020111600 | Cormier | Aug 2002 | A1 |
20030093040 | Mikszta | May 2003 | A1 |
20030125754 | Davis | Jul 2003 | A1 |
20040015139 | La Bianco | Jan 2004 | A1 |
20040064087 | Lastovich | Apr 2004 | A1 |
20040092959 | Bernaz | May 2004 | A1 |
20040167481 | Carlucci | Aug 2004 | A1 |
20040210214 | Knowlton | Oct 2004 | A1 |
20040236269 | Marchitto | Nov 2004 | A1 |
20040254587 | Park | Dec 2004 | A1 |
20050038448 | Chung | Feb 2005 | A1 |
20050143754 | Zelickson | Jun 2005 | A1 |
20050277950 | Pilcher | Dec 2005 | A1 |
20050278876 | Roth | Dec 2005 | A1 |
20050278877 | Akridge | Dec 2005 | A1 |
20060047234 | Glucksman | Mar 2006 | A1 |
20060130266 | Brown | Jun 2006 | A1 |
20060130335 | Suen | Jun 2006 | A1 |
20070293795 | Carroll | Dec 2007 | A1 |
20090005659 | Kollias | Jan 2009 | A1 |
20090124985 | Hasenoehrl | May 2009 | A1 |
20090157094 | Yeshurun | Jun 2009 | A1 |
20090177125 | Pilcher | Jul 2009 | A1 |
20090177171 | Ignon | Jul 2009 | A1 |
20090198159 | Linzell | Aug 2009 | A1 |
20100049177 | Boone, III | Feb 2010 | A1 |
20100242201 | Linzell | Sep 2010 | A1 |
20110120487 | Rollat-Corvol | May 2011 | A1 |
20120233798 | Brewer | Sep 2012 | A1 |
20130060176 | Nichols | Mar 2013 | A1 |
20130204178 | Luzon | Aug 2013 | A1 |
20140148823 | Fitzsimons | May 2014 | A1 |
20140305458 | Brewer | Oct 2014 | A1 |
20140330289 | Revivo | Nov 2014 | A1 |
20150202114 | Pardoel | Jul 2015 | A1 |
Number | Date | Country |
---|---|---|
101128136 | Feb 2008 | CN |
2004064567 | Aug 2004 | WO |
2005065551 | Jul 2005 | WO |
2005091748 | Oct 2005 | WO |
Entry |
---|
International Preliminary Report on Patentability dated Jul. 14, 2015, issued in corresponding International Application No. PCT/US2014/063216, filed Oct. 30, 2014, 7 pages. |
International Search Report dated Feb. 25, 2015, issued in corresponding International Application No. PCT/US2014/063216, filed Oct. 30, 2014, 6 pages. |
Written Opinion dated Feb. 25, 2015, issued in corresponding International Application No. PCT/US2014/063216, filed Oct. 30, 2014, 6 pages. |
De Boer, M., et al., “Guidelines for Etching Silicon MEMS Structures Using Fluorine High-Density Plasmas at Cryogenic Temperature,” Journal of Microelectromechanical Systems 11(4):385-401, Aug. 2002. |
Falke., M., “Mechanical Behaviour of Human Epidermal and Dermal Layers in Vivo,” PhD Dissertation, Technische Universiteit Eindhoven,The Netherlands, 2005, 119 pages. |
Geerligs, M., “A Literature Review of the Mechanical Behavior of the Stratum Corneum, the Living Epidermis and the Subcutaneous Fat Tissue,” Technical Note PR-TN 2006/00450, Philips Research Europe, Jun. 2006, 39 pages. |
O'Mahony, C., “Silicon-Based Microneedles for Painless Percutaneous Penetration,” Tyndall National Institute <http://www.tyndall.ie/content/microneedle-technology> [retrieved Sep. 10, 2014], 7 pages. |
White, C., and Frangos, J., “The Shear Stress of It All: the Cell Membrane and Mechanochennical Transduction,” Philosophical Transactions of the Royal Society B 362(1484):1459-1467, Aug. 2007. |
Notification of the First Office Action dated Jul. 9, 2018, issued in corresponding Chinese Application No. 201480065454.5, filed Oct. 30, 2014, 20 pages. |
Number | Date | Country | |
---|---|---|---|
20150182246 A1 | Jul 2015 | US |